Biomarin Pharmaceutical Inc (BMRN)
81.27
-0.45
(-0.55%)
USD |
NASDAQ |
May 10, 11:44
Biomarin Pharmaceutical Debt to Equity Ratio: 0.2144 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.2144 |
December 31, 2023 | 0.2195 |
September 30, 2023 | 0.2218 |
June 30, 2023 | 0.2269 |
March 31, 2023 | 0.2327 |
December 31, 2022 | 0.2353 |
September 30, 2022 | 0.2368 |
June 30, 2022 | 0.24 |
March 31, 2022 | 0.246 |
December 31, 2021 | 0.253 |
September 30, 2021 | 0.2527 |
June 30, 2021 | 0.2539 |
March 31, 2021 | 0.2586 |
December 31, 2020 | 0.2618 |
September 30, 2020 | 0.3573 |
June 30, 2020 | 0.4459 |
March 31, 2020 | 0.2632 |
December 31, 2019 | 0.2716 |
September 30, 2019 | 0.2744 |
June 30, 2019 | 0.2834 |
March 31, 2019 | 0.2843 |
December 31, 2018 | 0.2798 |
September 30, 2018 | 0.4118 |
June 30, 2018 | 0.413 |
March 31, 2018 | 0.4214 |
Date | Value |
---|---|
December 31, 2017 | 0.4182 |
September 30, 2017 | 0.4144 |
June 30, 2017 | 0.2419 |
March 31, 2017 | 0.2495 |
December 31, 2016 | 0.247 |
September 30, 2016 | 0.2554 |
June 30, 2016 | 0.3495 |
March 31, 2016 | 0.2917 |
December 31, 2015 | 0.2759 |
September 30, 2015 | 0.2913 |
June 30, 2015 | 0.2807 |
March 31, 2015 | 0.2703 |
December 31, 2014 | 0.4208 |
September 30, 2014 | 0.4355 |
June 30, 2014 | 0.4452 |
March 31, 2014 | 0.453 |
December 31, 2013 | 0.4888 |
September 30, 2013 | 0.0613 |
June 30, 2013 | 0.0873 |
March 31, 2013 | 0.0879 |
December 31, 2012 | 0.3428 |
September 30, 2012 | 0.3431 |
June 30, 2012 | 0.3482 |
March 31, 2012 | 0.4512 |
December 31, 2011 | 0.4506 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2144
Minimum
Mar 2024
0.4459
Maximum
Jun 2020
0.2625
Average
0.2529
Median
Debt to Equity Ratio Benchmarks
Pfizer Inc | 0.7445 |
Eli Lilly and Co | 2.046 |
Merck & Co Inc | 0.8478 |
Bristol-Myers Squibb Co | 3.376 |
Moderna Inc | 0.00 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 6.873B |
Total Liabilities (Quarterly) | 1.799B |
Shareholders Equity (Quarterly) | 5.074B |
Current Ratio | 2.744 |
Net Debt Paydown Yield | -0.01% |